PT-141
USD54.99
BUNDLE & SAVE
*Discount will be automatically applied in cart
Free Shipping
on orders over $200
Damage protection
every order covered
Secure checkout
256-bit SSL
Every batch, independently verified.
The report below reflects the identity, purity and full-panel specification data released with this product.
| Parameter | Result | Specification |
|---|---|---|
| Appearance | Good | Meets spec |
| Purity | 99.91% · Pass | ≥ 95% |
| Net Peptide Content | 10.61mg | Report |
| Identity | Confirmed | Meets spec |
| Fentanyl Screen | Not Detected | Pass |
| Heavy Metals | Not Detected | Pass |
| Sterility | No Growth | Pass |
| Endotoxin | < 0.05 EU/mL | Reported |
Compound Information
Technical specifications
Molecular Profile
What Is PT-141?
Cyclic heptapeptide analog of alpha-MSH, active metabolite of Melanotan II
Type
CAS Number
Molecular Weight
Amino Acids
Molecular Formula
Sequence
Stability Information
Handle with care to maintain potency
Lyophilized (powder)
-20°C • protect from light
Reconstituted
2-8°C
Auto injector (Vyleesi)
Room temperature
Regulatory Information
Developed by Palatin Technologies, approved by FDA
Developer
Marketing
FDA Approval
Indication
Male Use
Trade Name
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
